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C677T mutation, XRCC1 gene (Arg194Trp), HOGG1 with TT genotype, xeroderma 
pigmentosum (XPF) (rs744154) increase susceptibility. Tumor suppressor genes: p53 (Arg / 
Arg), p53CD72 associated with genetic susceptibility to gastric cancer is an important 
biomarker. H. pylori infection and p53 mutation have been shown to have a synergistic effect. 
NM23 is the first confirmed suppressor gene for tumor metastases.  
Conclusions. The study is based on the analysis of genetic variants that confer a higher risk of 
CG and their interactions with environmental factors, respectively H. pylori infection. 
Candidate gene polymorphisms in gastric cancer susceptibility. A deeper understanding of the 
factors involved in the development and progression of CG may allow the identification of 
persons at risk and can provide useful predictive information for the subgroups of patients who 
need early treatment or surveillance strategies.  
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Introduction. Papillary Thyroid Cancer (PTC) is taking the 1st place in malign processes of 
endocrine system, being also the most studied problem in cases of thyroid gland cancer. PTC 
is taking 40-85% from the total of the thyroid cancer in the past few decades. This is because 
of the human activity in the past- pollution of the environment, the rise of the radioactivity in 
the water, air and ground, registered a sudden rise in morbidity in EU and USA. We would like 
to mention the genetic factor in etiology of PTC. It has been recently shown that these tumors 
commonly have one of three genetic alterations: BRAF point mutations, RET/PTC 
rearrangements, or RAS point mutations. This factor has to have a substantial role in precocious 
diagnosis of the cancer and prognosis after the chirurgical treatment.  
Aim of the study. To elucidate the role of the genetic modifications in pathogenesis and 
cancerogenesis of the disease 
Materials and methods. We performed a retrospective study on a group of 50 patients with 
thyroid cancer, who were investigated: clinical, ultrasound, histological and laboratory (thyroid 
hormone level) and treated in the oncological “Head and neck” department of the Institute of 
Oncology between December 15- May 30, 2019 . The study included primarily diagnosed cases 
with CPT after surgical intervention. Data on the main risk factors, demography and tumor 
location have been collected from medical records. We will classify the patients after age, sex, 
cancer stage, evolution rate, data about the family anamnesis: the presence if the thyroid 
nodular disease and the presence of another neoplastic processes in relatives.  
Results. 83% of patients were diagnosed with CPT, 80% are female, middle age of 
involvement of 51-60 years old (38%). We observe hypoplasia of the thyroid gland on 6 
patients (12%); hyperplasia of grade l-ll on 27 patients (54%); hyperplasia of grade lll-lV on 
16 patients (33%). According to hormonal levels, euthyroidism, had 18 patients (37%); 
hypothyroidism 10 patients (21%); hypothyroidism 21 patients (42%). CPT patients were 
diagnosed in pTNM following stages: st.l T1N0M0, 7 patients (15%); st.ll T2N0M0, 22 
patients (45%); st.lll T3N1M0, 15 patients (30%); st.lV T4N1M1, 5 patients (10%). From the 
studied group, 19 patients have relatives with nodular pathology of the thyroid gland (37%). 
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50% of the patients have an aggravated hereditary anamnesis. We studied the genealogical 
trees of the patients; we found out that: in 25 families of 2 and more relatives (gr.l and ll) with 
cancer (thyroid, colorectal, breast, ovarian, malignant melanoma cancer) and thyroid nodular 
pathology.  
Conclusions. From the point of view of molecular and genetic side, PTC is heterogeneously 
and it needs new approaches of genetic modifications in clinical practices. The proportion of 
patients with cancer is increasing with age, aggravated hereditary and personal anamnesis. It is 
necessary to introduce screening by genetic exam for high-risk patients.  
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Introduction. The increasing number of multidrug-resistant bacteria in the last decade has left 
clinicians with very few medication options, usually resulting in the use of more expensive 
treatments. The demand of new therapeutic approaches encourages the discovery of new 
natural products with possible antimicrobial activity.  
Aim of the study. Therefore, the aim of this study was to look for active substances that could 
be used as antibacterial agents. To achieve this objective, two different fractions 
(myxoxantophyll and phycocyanin) from Spirulina platensis were investigated. 
Myxoxanthophyll is a carotenoid glycoside yellowish pigment present in the photosynthetic 
apparatus of Arthrospira (Spirulina) platensis and phycocyanin is a protein complex, accessory 
pigment to chlorophyll also present in Spirulina platensis.  
Materials and methods. The cyanobacteria extracts were tested in vitro for their antibacterial 
proprieties against (Acinetobacter baumannii, Pseudomonas aeruginosa, Klebsiella 
pneumoniae, Staphylococcus aureus and coagulase-negative staphylococci) using macro 
dilution method Ericsson and Sheris. The Time-kill kinetics assay (CLSI M26) was used to 
study the bactericidal activity of the Spirulina platensis extracts against bacterial strains over 
the time.  
Results. By means of the broth macro dilution assay, it was found that microalga extracts 
possess pronounced antibacterial activity against Acinetobacter baumannii (MIC: 0,0275 
mg/ml for myxoxanthophyll and 0,18 mg/ml for phycocyanin). In the case of coagulase-
negative staphylococci the antimicrobial activity of Arthrospira platensis fractions was low. 
Gram-negative bacteria showed to be more sensitive to the action Spirulina platensis pigments 
than Gram-positive bacteria. Also, it was found that myxoxanthophyll possess bacteriostatic 
and bactericidal action at a lower concentration than the phycocyanin. At a concentration of 
0,04 mg/ml myxoxantophyll could kill 100% bacteria in approximately 4 hours, and the time-
kill for phycocyanin was about 8 hours at the concentration 0,72 mg/ml.  
